The Russian social network VK removed the mutual aid section from a diabetes community called “Nyura Sharikova. Sakharny Diabet” at Roskomnadzor’s request, the project’s founder Nyura Sharikova announced on April 21. The independent Russian investigative outlet iStories drew attention to her statement.
The removed section, called “I’ll Give Away Insulin,” had allowed members of the VK group — which has 32,000 subscribers — to freely give away or exchange blood glucose test strips, glucometers, and insulin needles, and to find insulin or continuous glucose monitoring systems.
Sharikova learned from VK’s support service that the section had been removed at Roskomnadzor’s request, on the basis of a ruling by Roszdravnadzor, Russia’s health products regulator, dated March 18. The ruling itself was not shown to her. A VK representative stated that the platform would not be able to restore content removed at a government agency’s request.
Judging by the VK group, Sharikova has since restored the “I’ll Give Away Insulin” section, though it contains no posts.
Data from the U.N. and the WHO as of early 2025 show that nearly 5.5 million people in Russia have diabetes — and specialists say up to half of all cases go undetected.
People with diabetes in Russia have complained of disruptions in drug supplies caused by procurement problems. In March, the Russian business daily Vedomosti reported that endocrinologists proposed that diabetes medications be dispensed primarily to working-age patients.
At Meduza, we are committed to transparency about our use of artificial intelligence in the newsroom. The story you’re reading was written by one of our living, breathing journalists and translated from Russian using an AI model configured to follow our strict editorial standards. This translation process is the result of extensive testing and refinements to ensure our English-language coverage is timely and accurate. A Meduza editor reviews every draft before publication.
If you find any errors in this translation, please contact us at [email protected].
To read Meduza’s exclusive content in English, please subscribe to our newsletter.
